Hims & Hers Health is trading 3.52% up at €26.48 after a broader U.S. growth-stock rally on August 27, 2026.

  • The Nasdaq Composite gained 1.45%, while the S&P 500 rose 0.69%, supporting risk appetite.
  • No fresh company-specific announcement clearly explains the move.
  • Investor concerns remain focused on Visa’s monitoring program and ongoing securities-law scrutiny.